Literature DB >> 28275399

Pneumo-Renal Syndrome in Anti- Neutrophil Cytoplasm Antibody (ANCA)-Associated Small-Vessel Vasculitis.

Iuliana Andreiana1, Simona Stancu1, Andreea Avram2, Ludmila Taran2, Gabriel Mircescu1.   

Abstract

OBJECTIVES: We aimed to evaluate the prevalence of lung hemorrhage, its determinants and its prognostic significance in adults patients with severe kidney involvement due to ANCA-associated vasculitis diagnosed and treated in a nephrology department.
MATERIAL AND METHODS: Seventy-five patients consecutively diagnosed by kidney biopsy with crescentic pauci-immune glomerulonephritis entered this cohort study and were grouped according to the presence of diffuse alveolar hemorrhage (DAH - diagnosed as diffuse alveolar pattern on chest radiographs and anemia without evidence of another external bleeding). ANCAs were assessed by capture PR3-ANCA and MPO-ANCA ELISA or by indirect immunofluorescence. OUTCOMES: Patients were followed for a median period of 38 (11.7; 65.8) months. The median age was 61.6 years. Median creatinine was 5.7 mg/dL and 17% of the patients needed temporary dialysis. Most of the patients (76%) had MPO-ANCA; 31% had pneumo-renal syndrome. DAH patients had more severe and active kidney disease, as reflected by higher serum creatinine (7.1 mg/dL vs 4.45 mg/dL; p=0.006) and higher hematuria (610/mm3 vs 230/mm3, p=0.003). The risk of DAH was not influenced by gender, age or ANCA specificity, but by smoking (smokers had a 4 (95%CI 1.18-14.2; p=0.002) times higher the risk of lung hemorrhage) and by season (patients diagnosed in winter and autumn had a 6 (95% CI 1.6-20.9; p=0.005) times higher the risk of lung hemorrhage). The proportion of responders and of patients with relapses, and time to maintenance dialysis or to death were similar irrespective to the occurrence of DAH at presentation.
CONCLUSION: In patients with ANCA associated pauci-immune glomerulonephritis, cold season, smoking and active kidney disease, but not ANCA specificity or inflammation were associated with lung hemorrhage. Although diffuse alveolar hemorrhage was the main cause of death, it was not related to short- or long-term outcome.

Entities:  

Year:  2015        PMID: 28275399      PMCID: PMC5327797     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  23 in total

Review 1.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients' features and prognostic factors.

Authors:  Alex Kostianovsky; Thomas Hauser; Christian Pagnoux; Pascal Cohen; Eric Daugas; Luc Mouthon; Pierre Miossec; Jean-François Cordier; Loic Guillevin
Journal:  Clin Exp Rheumatol       Date:  2012-05-11       Impact factor: 4.473

Review 3.  Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

Authors:  Anthony D Booth; Mike K Almond; Aine Burns; Peter Ellis; Gill Gaskin; Guy H Neild; Martin Plaisance; Charles D Pusey; David R W Jayne
Journal:  Am J Kidney Dis       Date:  2003-04       Impact factor: 8.860

4.  Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Authors:  S L Hogan; P H Nachman; A S Wilkman; J C Jennette; R J Falk
Journal:  J Am Soc Nephrol       Date:  1996-01       Impact factor: 10.121

5.  The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis.

Authors:  Richard A Watts; Janice Mooney; Jane Skinner; David G I Scott; Alex J Macgregor
Journal:  Rheumatology (Oxford)       Date:  2012-01-17       Impact factor: 7.580

6.  Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.

Authors:  Taewoo Lee; Adil Gasim; Vimal K Derebail; Yunro Chung; JulieAnne G McGregor; Sophia Lionaki; Caroline J Poulton; Susan L Hogan; J Charles Jennette; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

7.  ANCA-associated vasculitis with renal involvement: an outcome analysis.

Authors:  Sven Weidner; Steffen Geuss; Syrus Hafezi-Rachti; Andrea Wonka; Harald D Rupprecht
Journal:  Nephrol Dial Transplant       Date:  2004-04-06       Impact factor: 5.992

8.  Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease.

Authors:  C F Franssen; R O Gans; B Arends; C Hageluken; P M ter Wee; P G Gerlag; S J Hoorntje
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

9.  Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis.

Authors:  Anoek A E de Joode; Jan Stephan F Sanders; Coen A Stegeman
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-11       Impact factor: 8.237

Review 10.  Does infection play a role in the pathogenesis of pulmonary vasculitis?

Authors:  Stephen A Capizzi; Ulrich Specks
Journal:  Semin Respir Infect       Date:  2003-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.